Tirzepatide

Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide used extensively in metabolic and endocrine research. This 39-amino acid synthetic peptide represents a significant advancement in incretin-based research compounds. Key specifications: • Purity: 99% (HPLC verified) • Molecular Weight: 4813.5 Da • Form: Lyophilized powder • Storage: -20°C, protected from light The dual-agonist mechanism allows researchers to study synergistic effects of GIP and GLP-1 receptor activation on glucose metabolism, insulin secretion, and appetite signaling pathways. Tirzepatide has become essential for comparative studies in metabolic research. Includes Certificate of Analysis.